12(top 5%)
papers
990(top 2%)
citations
8(top 5%)
h-index
10(top 5%)
g-index
13
all documents
1.1K
doc citations
425
citing journals

Top Articles

#TitleJournalYearCitations
1Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trialLancet Oncology, The2020450
2Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robustJournal of Clinical Epidemiology2016306
3Patients report improvements in continuity of care when quality of life assessments are used routinely in oncology practice: Secondary outcomes of a randomised controlled trialEuropean Journal of Cancer2010150
4The rising incidence of anal cancer in England 1990–2010: a population‐based studyColorectal Disease201473
5NEOSCOPE: A randomised phase II study of induction chemotherapy followed by oxaliplatin/capecitabine or carboplatin/paclitaxel based pre-operative chemoradiation for resectable oesophageal adenocarcinomaEuropean Journal of Cancer201737
6A feasibility study testing four hypotheses with phase II outcomes in advanced colorectal cancer (MRC FOCUS3): a model for randomised controlled trials in the era of personalised medicine?British Journal of Cancer201427
7Identifying components in consent information needed to support informed decision making about trial participation: An interview study with women managing cancerSocial Science and Medicine201618
8The CAIRO and FOCUS Studies: Which Lesson Is to Be Learned?Oncologist200910
9Communication analysis in oncology care. Performance of a combination of a content analysis system and a global scalePsycho-Oncology20112
10Impact of information intervention on social distress; a randomised pilot studyBMJ Supportive and Palliative Care20110
11Health-Related Quality of Life (Hrqol) and Disease Symptoms in Patients (Pts) with Locally Advanced or Metastatic Breast Cancer (Mbc) Treated with Eribulin (Eri) or Capecitabine (Cap) in a Post Anthracycline and Taxane SettingAnnals of Oncology20140
12Quality of Life in a Randomised Double-Blind Phase III Trial of Cediranib (Azd2171) in Relapsed Platinum Sensitive Ovarian Cancer (Icon6)Annals of Oncology20140